Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Two Premier Pain Clinics
March 29 2022 - 9:00AM
Milestone Scientific Inc.
(NYSE:MLSS), a leading developer of computerized
drug delivery instruments, that provide painless and precise
injections, today announced that it has commenced sales of the
CompuFlo® Epidural disposables at the Cypress Surgery Center in
Santa Maria, California and the Galileo Surgery Center in San Luis
Obispo. Both of these prominent pain management practices are
located in California and owned by Pain Management Specialists.
Pain Management Specialists (PMS) is a group of specially
trained physicians, dedicated to the evaluation and treatment of
acute and chronic pain. Its physicians utilize the latest
techniques and apply the most current theories, to provide patients
with a comprehensive treatment plan, necessary to assist in their
fight against pain.
Arjan Haverhals, CEO and president of Milestone Scientific,
stated, “We continue to expand sales of our CompuFlo Epidural
system within pain clinics across the U.S. The selection of our
technology by these two clinics follows successful evaluation,
reinforcing the safety, economic and efficiency benefits, as well
as the improved patient experience.”
About Milestone Scientific
Inc.Milestone Scientific Inc. (MLSS), a technology focused
medical research and development company that patents, designs and
develops innovative injection technologies and instruments for
medical, dental and cosmetic applications. Milestone Scientific’s
computer-controlled systems are designed to make injections
precise, efficient and increase the overall patient comfort and
safety. Their proprietary DPS Dynamic Pressure Sensing Technology®
instruments is the platform to advance the development of
next-generation devices, regulating flow rate and monitoring
pressure from the tip of the needle, through platform extensions of
subcutaneous drug delivery, including local anesthetic. To learn
more, view the MLSS brand video or visit
milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking
statements regarding the timing and financial impact of Milestone's
ability to implement its business plan, expected revenues, timing
of regulatory approvals and future success. These statements
involve a number of risks and uncertainties and are based on
assumptions involving judgments with respect to future economic,
competitive and market conditions, future business decisions and
regulatory developments, all of which are difficult or impossible
to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual
results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure
to achieve expected revenue growth, changes in our operating
expenses, adverse patent rulings, FDA or legal developments,
competitive pressures, changes in customer and market requirements
and standards, and the risk factors detailed from time to time in
Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report
for the year ended December 31, 2020. The forward-looking
statements in this press release are based upon management's
reasonable belief as of the date hereof. Milestone undertakes no
obligation to revise or update publicly any forward-looking
statements for any reason.
Contact: David Waldman or Natalya
RudmanCrescendo Communications, LLCEmail: mlss@crescendo-ir.comTel:
212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Apr 2024 to May 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From May 2023 to May 2024